Velan (VLN.TO) reported a fiscal first-quarter adjusted net loss of $6.9 million, or $0.32 per share, swinging from a net income of $90,000, or $0.00 per share, in the year-ago quarter.
Sales for the quarter were $57.8 million, down from $72.2 million in the same quarter a year ago.
Golconda Gold (GG.V) on Thursday said second-quarter gold production at its Galaxy Gold Mine totaled 3,648 ounces, unchanged from the first quarter and up 20% from a year earlier.The company said it expects ore tonnes to increase in the second half of 2026 as in late Q2 it took delivery of additional mining equipment, including one drill rig, three loaders and one dump truck.The company also announced the appointment of High Desert Mining as mining contractor at the Summit Mine in New Mexico. High Desert has been on site since May 25 and underground establishment activities are underway with key mining equipment are mobilised."First ore was delivered to surface on July 7, mining faces are readily accessible and we expect to begin to build a stockpile," Golconda Gold CEO Ravi Sood said.Company's shares closed up C$0.07 to C$2.25 on TSX Venture Exchange.
Cineplex (CGX.TO) after trade Thursday said it generated C$55.8 million in box office revenue in June, compared with C$51.8 million a year ago.For the second quarter, box office revenue totaled C$176.2 million, up from C$158.5 million in the second quarter of 2025, the company said, adding that "through the first half of 2026, the strength of the slate was evident, with more 2026 releases surpassing $200 million at the domestic box office than in any year since 2018. June further contributed to this momentum, delivering the highest June box office performance since 2019".Toy Story 5 delivered the largest domestic opening weekend of the year, while Obsession and Backrooms were among the quarter's biggest breakout successes. Looking ahead, Chief Executive Ellis Jacob said that there is strong early demand for The Odyssey and Spider-Man: Brand New Day.
Tilray Brands' (TLRY.TO) Tilray Medical unit said Thursday it launched its first medical cannabis product in Panama.The launch follows the shipment of Tilray Oral Solution CBD100 from the company's EU-GMP-certified production facility in Portugal through its joint venture with Solana Life Group. The product will be distributed through Farmacias Arrocha, one of Panama's pharmacy chains, and will be available to patients by prescription, the company said.The solution is "intended for use, where authorized, in patients with qualifying medical conditions authorized under Panamanian legislation," the company added.